flumazenil has been researched along with dihydropyridines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayden, HC; Herbette, LG; Mason, RP; Moring, J; Salomon, RM; Shoemaker, WJ; Skita, V | 1 |
| Bell-Horner, CL; Chen, ZL; Covey, DF; Das, P; Dillon, GH; Gonzales, EB; Huang, RQ; Raut, A | 1 |
2 other study(ies) available for flumazenil and dihydropyridines
| Article | Year |
|---|---|
Rat cerebral cortical synaptoneurosomal membranes. Structure and interactions with imidazobenzodiazepine and 1,4-dihydropyridine calcium channel drugs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Anti-Anxiety Agents; Calcium Channel Blockers; Cell Membrane; Cerebral Cortex; Dihydropyridines; Flumazenil; Microscopy, Electron; Models, Molecular; Myelin Basic Protein; Neurons; Nimodipine; Protein Conformation; Rats; Receptors, Cholinergic; Receptors, GABA-A; Ryanodine Receptor Calcium Release Channel; Synaptosomes; X-Ray Diffraction | 1990 |
Inhibition of type A GABA receptors by L-type calcium channel blockers.
Topics: 4-Butyrolactone; Animals; Benzodiazepines; Binding Sites; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Dihydropyridines; Flumazenil; GABA Modulators; GABA-A Receptor Antagonists; Humans; Hypothalamus; Kidney; Mutagenesis, Site-Directed; Nitrendipine; Picrotoxin; Protein Structure, Tertiary; Rats; Receptors, GABA-A; Recombinant Proteins; Solvents; Species Specificity; Zinc | 2004 |